MTOR and cancer: In fact, BAP1 mutations in tumors are associated with pathological features of aggressive disease including high Fuhrman grade [118,122,151,153], metastatic disease at presentation, worse cancer specific survival, instantaneous activation of mTOR signaling, and activation of pathways implicated in growth factors [118,122,151,153].